<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Self-expandable metal stents (SEMS) have been used as a bridging or palliative treatment for malignant colorectal obstruction </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0235328" disease_type="Disease or Syndrome" abbrv="">Colonic obstruction</z:e> also may arise from advanced extracolonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, but the clinical outcomes of stent placement for extracolonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> are unclear </plain></SENT>
<SENT sid="2" pm="."><plain>This study compared the clinical outcomes of SEMS between patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and those with extracolonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Patients who underwent endoscopic SEMS placement for a malignant colorectal obstruction were enrolled at Seoul National University Hospital from April 2005 and August 2011 </plain></SENT>
<SENT sid="4" pm="."><plain>Their medical records were retrospectively reviewed in terms of success rate, complications, and duration of stent patency </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Endoscopic SEMS placements were performed for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in 149 patients and for extracolonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in 60 patients </plain></SENT>
<SENT sid="6" pm="."><plain>The causes of obstruction in extracolonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> were advanced <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> in 39 patients (65%), <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> in nine patients (15%), <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e> in three patients (5%) and other causes in nine patients (15%) </plain></SENT>
<SENT sid="7" pm="."><plain>The clinical success rates were similar between the two groups (92.6 vs 86.7%; p = 0.688), and multivariate analysis showed no significant risk factor for unsuccessful endoscopic SEMS placement </plain></SENT>
<SENT sid="8" pm="."><plain>Reobstruction in palliative endoscopic SEMS placement occurred for 16 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (21.9%) and 18 patients with extracolonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> (30%) during a median follow-up period of 90 days (p = 0.288) </plain></SENT>
<SENT sid="9" pm="."><plain>The rates did not differ significantly between the two groups (4.1 vs 8.3%; p = 0.467) </plain></SENT>
<SENT sid="10" pm="."><plain>The median duration of stent patency was 193 ± 42 days for the patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and 186 ± 31 days for the patients with extracolonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> (p = 0.253) </plain></SENT>
<SENT sid="11" pm="."><plain>The duration of stent patency was not affected by underlying <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, previous surgery, or palliative chemotherapy </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Endoscopic SEMS placement is highly effective and comparable for palliation of obstruction in extracolonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in terms of clinical success, complications, and duration of patency </plain></SENT>
</text></document>